CXCL10 and neoplasm: Cancer cells in which β-catenin signalling is activated have low chemokine (C-C motif) ligand 4 production and suppress the accumulation of conventional DC (cDC1), which produces chemokine (C-X-C motif) ligand 10 (CXCL10) in the tumour, thereby hindering T cell infiltration [256,257,258].